|Articles|April 14, 2023

Pharma USA 2023: Digital Therapeutics and Pharma

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

2026 Pharm Exec Top 50 Companies

ByMichael Christel

August 14th 2026

From Value Imperative to Operating Reality: Rethinking Trust in Pharma

ByMorten Nielsen,Saule Serikova,Susan M. Snyder

August 14th 2026

Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs

ByMichael Christel,Glenn Hunzinger

August 14th 2026

Tyler Seville

The Impact from Overlaps Between 340B and the IRA

ByMike Hollan,Tyler Seville

August 14th 2026

2026 Emerging Pharma Leaders

August 13th 2026

Trending on PharmExec

From Value Imperative to Operating Reality: Rethinking Trust in Pharma

Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs

2026 Pharm Exec Top 50 Companies

Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors

FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma